论文部分内容阅读
AIM To investigate efficacy and safety of second-linetreatment with irinotecan-loaded drug-eluting beads(DEBIRI) and cetuximab (DEBIRITUX) of unresectablecolorectal liver metastases.METHODS: Patients with the following characteristicswere included in the